Analyst Consensus ?
ConsensusBuy43 ratings
Bullish2353.5%
Neutral1841.9%
Bearish24.6%
Chubb Limited · CB · FY2024 Q3 · Calendar Q4 2024
Chubb posts strong Q3; pricing and investment income support growth
The current analysis supports a constructive operating thesis for Chubb: resilient pricing, disciplined underwriting, investment income, and international growth are supporting earnings momentum. The evidence is balanced by catastrophe, casualty-reserve, competitive, interest-rate, and tax risks.
Reported After market closeNYSEFinancial Services
$137.00B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$5.72
Consensus $4.98
EPS surprise
+14.9%
Reported versus consensus
Reported revenue
$14.87B
Consensus $14.16B
Revenue surprise
+5.0%
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-1.2%
Event window
SPY move
-0.3%
Same window
Abnormal move
-0.9%
Stock minus SPY
Volume
1.5×
Versus trailing sessions
Subsequent drift
+2.4%
Up to 20 sessions
CBSPY benchmark
Ask FN2 about CB FY2024 Q3
Transcript, numbers and history already loaded
Why did CB fall 1.2% after beating EPS estimates in FY2024 Q3?What changed in CB's guidance and outlook in FY2024 Q3?Give me the bull and bear case for CB after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Compared with the prior analysis, the current quarter adds evidence of strong underwriting and investment income, lower-than-modeled catastrophe losses, and continued pricing strength. It also flags increasing London wholesale competition, adverse long-tail casualty development, and potential tax-rate changes as more prominent risks.
Guidance delta
No formal guidance was provided in the current analysis. Management remained confident while emphasizing disciplined underwriting, investment growth, and international expansion.
Key takeaways
- The current analysis describes a strong Q3, led by underwriting performance and record investment income.
- Property and casualty pricing remained robust relative to loss-cost trends, supporting underwriting momentum.
- International growth, especially in Asia Pacific and Latin America, contrasted with increasing competition in London wholesale.
- The prior quarter’s focus on disciplined growth, digital distribution, and Accident & Health broadened into continued global expansion and capital flexibility.
Management priorities
- Maintain disciplined underwriting and expand profitable property, casualty, and high-net-worth personal-lines business.
- Grow invested assets while seeking superior risk-adjusted returns.
- Pursue international growth, particularly in Asia Pacific and Latin America, while returning capital through repurchases and dividends.
Follow CB with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$355.11Current
$170Low
$313.11Average
$387High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 24, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Oct 22, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Oct 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Oct 22, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 21, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Oct 12, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 6, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 22, 2026 |
| Piper Sandler | Neutral | Neutral | Maintain | Jul 15, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 10, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 8, 2026 |
| HSBC | Hold | Buy | Downgrade | Jul 6, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jun 12, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Apr 14, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 23, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Feb 10, 2026 |
| Raymond James | Strong Buy | Strong Buy | Maintain | Feb 9, 2026 |
| Roth Capital | Buy | Buy | Maintain | Feb 4, 2026 |
| Goldman Sachs | Buy | Neutral | Upgrade | Jan 8, 2026 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Oct 22, 2025 |
| Jefferies | Hold | Hold | Maintain | Apr 11, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Jan 30, 2025 |
| Roth MKM | Buy | Buy | Maintain | Jul 24, 2024 |
| William Blair | Underperform | Market Perform | Downgrade | Jun 28, 2024 |
| MKM Partners | Buy | Buy | Maintain | Dec 5, 2022 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Nov 15, 2022 |
| Credit Suisse | Outperform | Outperform | Maintain | Nov 1, 2021 |
| Wolfe Research | Outperform | Outperform | Maintain | Aug 17, 2021 |
| Argus Research | Buy | Hold | Upgrade | Jul 30, 2021 |
| Compass Point | Neutral | Buy | Downgrade | May 29, 2019 |
| Sandler O'Neill | Hold | Buy | Downgrade | Apr 3, 2019 |
| Argus | Hold | Hold | Maintain | Apr 6, 2018 |
| PiperJaffray | Overweight | Overweight | Maintain | Oct 15, 2015 |
| Sterne Agee CRT | Buy | Buy | Maintain | Sep 21, 2015 |
| Bernstein | Outperform | Market Perform | Upgrade | Jul 31, 2015 |
| Janney Montgomery Scott | Buy | Neutral | Upgrade | Jul 24, 2015 |
| Janney Capital | Buy | Neutral | Upgrade | Jul 24, 2015 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Jul 6, 2015 |
| Nomura | Neutral | Neutral | Maintain | Apr 25, 2014 |
| Evercore Partners | Equal Weight | Overweight | Downgrade | Dec 13, 2013 |
| Miller Tabak | Hold | Buy | Downgrade | Oct 3, 2013 |
| Guggenheim | Buy | Buy | Maintain | Sep 18, 2013 |
| Sterne Agee | Buy | Buy | Maintain | Jun 26, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $355.11. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Mizuho Securities | Analyst unavailable | $350 | $354.95 | -1.4% | Oct 22, 2026 |
| Wells Fargo | Analyst unavailable | $343 | $341.2 | -3.4% | Oct 12, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $333 | $334.21 | -6.2% | Oct 7, 2026 |
| HSBC | Vikram Gandhi | $359 | $334.21 | +1.1% | Oct 7, 2026 |
| Mizuho Securities | Yaron Kinar | $347 | $341.86 | -2.3% | Sep 16, 2026 |
| Morgan Stanley | Bob Huang | $360 | $345.29 | +1.4% | Aug 19, 2026 |
| Wells Fargo | Analyst unavailable | $356 | $343.23 | +0.3% | Jul 23, 2026 |
| Deutsche Bank | Cave Montazeri | $354 | $341.6 | -0.3% | Jul 22, 2026 |
| Atlantic Equities | Analyst unavailable | $301 | $339.6 | -15.2% | Jul 15, 2026 |
| Piper Sandler | Analyst unavailable | $374 | $346.22 | +5.3% | Jul 15, 2026 |
| Evercore ISI | Analyst unavailable | $374 | $345.34 | +5.3% | Jul 10, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $337 | $355.09 | -5.1% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $352 | $355.09 | -0.9% | Jul 9, 2026 |
| UBS | Brian Meredith | $369 | $356.49 | +3.9% | Jul 8, 2026 |
| Barclays | Analyst unavailable | $387 | $356.53 | +9.0% | Jul 7, 2026 |
| Morgan Stanley | Analyst unavailable | $340 | $361.17 | -4.3% | Jul 6, 2026 |
| HSBC | Vikram Gandhi | $373 | $361.17 | +5.0% | Jul 6, 2026 |
| Barclays | Analyst unavailable | $368 | $327.93 | +3.6% | Jun 12, 2026 |
| Wells Fargo | Elyse Greenspan | $333 | $325.43 | -6.2% | Apr 23, 2026 |
| BMO Capital | Michael Zaremski | $326 | $326.17 | -8.2% | Feb 10, 2026 |
| UBS | Analyst unavailable | $340 | $331.56 | -4.3% | Feb 9, 2026 |
| Seaport Global | Analyst unavailable | $373 | $330.7 | +5.0% | Feb 9, 2026 |
| Mizuho Securities | Analyst unavailable | $336 | $331.28 | -5.4% | Feb 6, 2026 |
| Goldman Sachs | Analyst unavailable | $366 | $331.28 | +3.1% | Feb 5, 2026 |
| Roth Capital | Analyst unavailable | $360 | $332.15 | +1.4% | Feb 4, 2026 |
| HSBC | Analyst unavailable | $354 | $299.96 | -0.3% | Jan 16, 2026 |
| Morgan Stanley | Analyst unavailable | $350 | $301.11 | -1.4% | Jan 16, 2026 |
| Mizuho Securities | Analyst unavailable | $317 | $300.69 | -10.7% | Jan 14, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $309 | $300.69 | -13.0% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $305 | $306.62 | -14.1% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $339 | $306.63 | -4.5% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $351 | $306.63 | -1.2% | Jan 7, 2026 |
| Evercore ISI | David Motemaden | $346 | $307.52 | -2.6% | Jan 7, 2026 |
| Morgan Stanley | Bob Huang | $310 | $312.54 | -12.7% | Dec 16, 2025 |
| Mizuho Securities | Analyst unavailable | $318 | $312.54 | -10.5% | Dec 15, 2025 |
| Goldman Sachs | Alex Scott | $309 | $281.68 | -13.0% | Oct 27, 2025 |
| UBS | Analyst unavailable | $298 | $281.02 | -16.1% | Oct 27, 2025 |
| Cantor Fitzgerald | Analyst unavailable | $300 | $281.12 | -15.5% | Oct 27, 2025 |
| BMO Capital | Michael Zaremski | $283 | $281.16 | -20.3% | Oct 23, 2025 |
| Wells Fargo | Analyst unavailable | $293 | $276.52 | -17.5% | Oct 23, 2025 |
| Barclays | Analyst unavailable | $310 | $289.24 | -12.7% | Oct 8, 2025 |
| Evercore ISI | Analyst unavailable | $315 | $282.76 | -11.3% | Oct 1, 2025 |
| Wolfe Research | Tracy Benguigui | $320 | $274.33 | -9.9% | Sep 15, 2025 |
| Evercore ISI | David Motemaden | $312 | $270.15 | -12.1% | Jul 23, 2025 |
| Barclays | Alex Scott | $298 | $283.19 | -16.1% | Jul 7, 2025 |
| UBS | Brian Meredith | $304 | $282.18 | -14.4% | Apr 28, 2025 |
| Wells Fargo | Elyse Greenspan | $278 | $282 | -21.7% | Apr 24, 2025 |
| HSBC | Analyst unavailable | $323 | $287.01 | -9.0% | Mar 5, 2025 |
| Morgan Stanley | Michael Phillips | $300 | $283.76 | -15.5% | Oct 30, 2024 |
| Bank of America Securities | Joshua Shanker | $282 | $282.83 | -20.6% | Oct 10, 2024 |
| Bank of America Securities | Joshua Shanker | $275 | $288.54 | -22.6% | Oct 4, 2024 |
| Barclays | Alex Scott | $349 | $290.94 | -1.7% | Sep 4, 2024 |
| Bank of America Securities | Joshua Shanker | $264 | $263.25 | -25.7% | Jul 24, 2024 |
| Morgan Stanley | Bob Huang | $259 | $253.34 | -27.1% | Jul 10, 2024 |
| Evercore ISI | David Motemaden | $278 | $252.97 | -21.7% | May 16, 2024 |
| RBC Capital | Mark Dwelle | $285 | $243.01 | -19.7% | Apr 25, 2024 |
| HSBC | Vikram Gandhi | $270 | $254.79 | -24.0% | Apr 4, 2024 |
| Citigroup | Analyst unavailable | $229 | $216.25 | -35.5% | Feb 8, 2023 |
| Jefferies | Analyst unavailable | $246 | $227.18 | -30.7% | Jan 9, 2023 |
| RBC Capital | Analyst unavailable | $250 | $219.96 | -29.6% | Dec 14, 2022 |
| MKM Partners | Analyst unavailable | $260 | $216.79 | -26.8% | Dec 5, 2022 |
| Morgan Stanley | Analyst unavailable | $220 | $211.85 | -38.0% | Nov 22, 2022 |
| Raymond James | Analyst unavailable | $260 | $184.79 | -26.8% | Jul 28, 2022 |
| Wells Fargo | Analyst unavailable | $250 | $187 | -29.6% | Jul 28, 2022 |
| Morgan Stanley | Michael Phillips | $216 | $207.31 | -39.2% | May 24, 2022 |
| Barclays | Tracy Benguigui | $249 | $204 | -29.9% | May 22, 2022 |
| Raymond James | Gregory Peters | $250 | $206.45 | -29.6% | May 1, 2022 |
| Barclays | Tracy Benguigui | $250 | $206.45 | -29.6% | Apr 30, 2022 |
| RBC Capital | Analyst unavailable | $243 | $210.62 | -31.6% | Apr 28, 2022 |
| Barclays | Tracy Benguigui | $244 | $210.52 | -31.3% | Apr 16, 2022 |
| RBC Capital | Mark Dwelle | $239 | $212.58 | -32.7% | Apr 7, 2022 |
| Goldman Sachs | Alex Scott | $237 | $206.74 | -33.3% | Feb 2, 2022 |
| Evercore ISI | David Motemaden | $233 | $207.53 | -34.4% | Feb 2, 2022 |
| Wells Fargo | Elyse Greenspan | $230 | $206.74 | -35.2% | Feb 2, 2022 |
| JMP Securities | Matthew Carletti | $225 | $195.52 | -36.6% | Jan 14, 2022 |
| Credit Suisse | Andrew Kligerman | $225 | $190.79 | -36.6% | Nov 1, 2021 |
| Bank of America Securities | Joshua Shanker | $156 | $176.91 | -56.1% | Oct 7, 2021 |
| Deutsche Bank | Phil Stefano | $170 | $162.59 | -52.1% | Jul 12, 2021 |
Track every rating change on CB the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationChubb Limited, headquartered in Zurich, Switzerland, is a global insurer and reinsurer, offering a broad spectrum of products across various markets. In North America, its Commercial Property & Casualty (P&C) division caters to businesses of all scales, from large corporations to small enterprises, providing a wide range of policies. These encompass commercial property, casualty, workers' compensation, package deals, risk management, financial lines, marine, construction, environmental, medical, cyber risk, surety, and excess casualty, alongside group accident and health insurance. The North America Personal P&C unit serves affluent individuals and high-net-worth families, delivering coverage for homeowners, automobiles (including collector vehicles), valuable possessions, personal and excess liability, travel, and recreational marine risks, complete with related services.…
Historical context
All CB earningsFinancial Services peers this season
Latest reports in the same sector
Latest beats and misses
Who reports nextBeat on EPS
- FCNCAFY2026 Q3 · October 23, 2026+19.9% EPS+8.2% move
- FCNCNFY2026 Q3 · October 23, 2026+19.9% EPS+0.2% move
- FCNCOFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- FCNCPFY2026 Q3 · October 23, 2026+19.9% EPS+1.0% move
- RDYFY2027 Q2 · October 23, 2026+24.0% EPS-0.2% move
- SLBFY2026 Q3 · October 23, 2026+3.7% EPS+7.1% move
Missed on EPS
- INFYFY2027 Q2 · October 23, 2026-4.8% EPS-6.6% move
- BBDFY2026 Q3 · October 22, 2026-7.7% EPS+3.0% move
- SNAFY2026 Q3 · October 22, 2026-5.9% EPS-3.4% move
- SPOTFY2026 Q3 · October 22, 2026-11.6% EPS+11.1% move
- VRSNFY2026 Q3 · October 22, 2026-2.0% EPS-0.9% move
- HBANMFY2026 Q3 · October 22, 2026-5.3% EPS+0.5% move
Get the CB recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:38:36.707185+00:00
- Polygon adjusted daily market bars · 2026-10-24T16:00:41.726065+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-24T16:00:41.723264+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-24. For educational purposes only; not investment advice.